Agnati L F, Benfenati F, Cortelli P, D'alessandro R, Ghisoli E, Zampa G A
Neurosci Lett. 1979 May;12(2-3):307-11. doi: 10.1016/0304-3940(79)96080-4.
The effects of 2-Br-alpha-ergocryptine (2.5 mg/osM), clonidine (50 microgram, intramuscularly) and naloxone (0.4 mg, intramuscularly) as well as the interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone (LH) follicle-stimulating hormone (FSH), prolactin (PL) and thyroid-stimulating hormone (TSH) serum levels in normal man have been studied. 2-Br-alpha-ergocryptine and clonidine clearly reduce and naloxone tends to reduce PL serum levels. TSH levels are lowered by naloxone as well by clonidine plus naloxone. The results obtained point also to a possible different pattern of LH and FSH secretion after naloxone, that is after opiate receptor blockade. The clonidine effects on PL secretion are discussed in the frame of a possible adrenergic control of the release of this hormone.
研究了2-溴-α-麦角隐亭(2.5毫克/口服)、可乐定(50微克,肌肉注射)和纳洛酮(0.4毫克,肌肉注射)以及纳洛酮与2-溴-α-麦角隐亭或可乐定之间的相互作用对正常男性血清促黄体生成素(LH)、促卵泡生成素(FSH)、催乳素(PL)和促甲状腺激素(TSH)水平的影响。2-溴-α-麦角隐亭和可乐定明显降低血清PL水平,纳洛酮也有降低血清PL水平的趋势。纳洛酮以及可乐定加纳洛酮均可降低TSH水平。所得结果还表明,纳洛酮作用后,即阿片受体阻断后,LH和FSH的分泌模式可能不同。在该激素释放可能受肾上腺素能控制的框架内,讨论了可乐定对PL分泌的影响。